BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34661724)

  • 21. Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis.
    Vuong HG; Nguyen TPX; Pham N; Dunn IF
    Pituitary; 2021 Jun; 24(3):429-437. PubMed ID: 33205233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants.
    Dawoud FM; Naylor RM; Giannini C; Swanson AA; Meyer FB; Uhm JH
    Clin Neurol Neurosurg; 2020 Sep; 196():106059. PubMed ID: 32682222
    [No Abstract]   [Full Text] [Related]  

  • 23. Spindle cell oncocytoma of the pituitary and pituicytoma: Two tumors mimicking pituitary adenoma.
    Ogiwara H; Dubner S; Shafizadeh S; Raizer J; Chandler JP
    Surg Neurol Int; 2011; 2():116. PubMed ID: 21886889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spindle cell oncocytoma with late recurrence and unique neuroimaging characteristics due to recurrent subclinical intratumoral bleeding.
    Borges MT; Lillehei KO; Kleinschmidt-DeMasters BK
    J Neurooncol; 2011 Jan; 101(1):145-54. PubMed ID: 20495848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The 2017 WHO classification of pituitary tumors].
    Saeger W
    Pathologe; 2021 May; 42(3):333-351. PubMed ID: 33877399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is spindle cell oncocytoma a true entity or a variant of pituicytoma? A case report with review of literature.
    Gupta RK; Batra VV; Singh D; Sharma MC; Kumar V
    Neurol India; 2018; 66(5):1413-1418. PubMed ID: 30233016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spindle cell oncocytoma: Report of two cases with massive bleeding and review of the literature.
    Billeci D; Marton E; Giordan E; Carraro V; Ronzon M; Rossi S
    J Clin Neurosci; 2017 May; 39():39-44. PubMed ID: 28286028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
    Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
    Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
    Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
    J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up.
    Vajtai I; Sahli R; Kappeler A
    Pathol Res Pract; 2006; 202(10):745-50. PubMed ID: 16884858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumors of the Neurohypophysis: One Unit's Experience and Literature Review.
    Borg A; Jaunmuktane Z; Dorward N
    World Neurosurg; 2020 Feb; 134():e968-e978. PubMed ID: 31734425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spindle Cell Oncocytoma of the Anterior Pituitary Presenting with an Acute Clinical Course Due To Intraventricular Hemorrhage. A Case Report and Review of Literature.
    Osman M; Wild A
    Am J Case Rep; 2017 Aug; 18():894-901. PubMed ID: 28814709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple recurrences require long-term follow-up in patients diagnosed with spindle cell oncocytoma of the sella turcica.
    Manoranjan B; Koziarz A; Kameda-Smith MM; Provias JP
    J Clin Neurosci; 2017 Sep; 43():134-146. PubMed ID: 28668473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.
    Bi WL; Greenwald NF; Ramkissoon SH; Abedalthagafi M; Coy SM; Ligon KL; Mei Y; MacConaill L; Ducar M; Min L; Santagata S; Kaiser UB; Beroukhim R; Laws ER; Dunn IF
    Endocrinology; 2017 Jul; 158(7):2284-2291. PubMed ID: 28486603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spindle cell oncocytoma of adenohypophysis: Review of literature and report of another recurrent case.
    Sali A; Epari S; Tampi C; Goel A
    Neuropathology; 2017 Dec; 37(6):535-543. PubMed ID: 28631277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas.
    Miyake Y; Adachi JI; Suzuki T; Mishima K; Araki R; Mizuno R; Nishikawa R
    J Neurooncol; 2019 Jan; 141(1):131-138. PubMed ID: 30392088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary.
    Soukup J; Kasparova P; Kohout A; Rychly B; Skarkova V; Syrucek M; Gabalec F
    Pituitary; 2019 Feb; 22(1):70-78. PubMed ID: 30607746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.